FDA Approves, Leqembi, New Treatment for Early Alzheimer’s

The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.

A recent paper that we got published with Vivan Welch teams and others on research priority setting related to older adults - -it is increasingly important to review what priority setting exercise already done before conducting new ones https://pubmed.ncbi.nlm.nih.gov/36123060/ #researchprioritysetting #review #prioritysetting
Research priority setting related to older adults: a scoping review to inform the Cochrane-Campbell Global Ageing Partnership work programme - PubMed

Future priority setting initiatives should focus on documenting a more detailed methodology with all initiatives eliciting opinions from caregivers and older adults to ensure priorities reflect the opinions of all key stakeholder groups.

PubMed